Elena Olegovna Samoilovich

Elena Olegovna Samoilovich

Auto-generated profile, based on publicly available information

Elena Olegovna Samoilovich

Researche instityte of hygiene, toxicology, epidemiology, virology and microbiology of the Republican Center of Hygiene, Epidemiology and Public Health

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2007 in Journal of General Virology
Verified
Journal Article
Open access
PDF file
JHJudith M. Hübschen
Judith M. Hübschen
MYMarina Yermalovich
Marina Yermalovich
GSGalina Semeiko
Galina Semeiko
ESElena Samoilovich
Elena Samoilovich
EBElena Blatun
Elena Blatun
CMClaude P. Muller
Claude P. Muller
Although the WHO recommends a comprehensive genetic characterization, little is known about circulating strains and genotypes of rubella virus (RUBV) for many European countries. Studies investigating the genetic diversity of a sizeable number of strains from a certain location are rare. This study presents the first molecular characterization of isolates from Belarus. Throat swab and urine samples were collected between 2004 and 2005 from patients presenting in two infectious disease hospitals and three outpatient clinics in and around Minsk. In total, 14 isolates were obtained from this clinical material. Phylogenetic analysis of the E1 gene sequence of these isolates showed that three distinct groups of RUBV strains co-circulated. One group of isolates was assigned to genotype 1E, whereas the other two did not group with any of the recognized genotypes but grouped with a strain belonging to the provisional genotype 1g. Detailed analysis showed that the group comprising 1g strains also contained sequences formerly attributed to genotype 1B and could be divided into four subgroups, one of which might represent a putative novel provisional genotype of clade 1. These findings show that three distinct strains with limited variability are present in Belarus, suggesting independent introductory events. As there currently seem to be misattributions of strains to genotypes and unclear phylogenetic relationships, criteria for genotyping of RUBV should be clarified further.

7 October 2021 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
PDF file
APA. Yu. Popova
A. Yu. Popova
ATA. A. Tarasenko
A. A. Tarasenko
VSV. Yu. Smolensky
V. Yu. Smolensky
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
VSViacheslav Smirnov
Viacheslav Smirnov
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Objective was to investigate the SARS-CoV-2 collective immunity status of the population of Belarus within the context of the COVID-19 pandemic. Materials and methods. The work was carried out according to the methodology for assessing SARS-CoV-2 population immunity, developed by Rospotrebnadzor Russia and the Ministry of Health of Belarus with the participation of the St. Petersburg Pasteur Institute, taking into account WHO recommendations. The Bioethics Committee of Belarus and the local ethics committee of the St. Petersburg Pasteur Institute approved the study. Selection of participants was carried out using a questionnaire method and online technology (internet, cloud server). Volunteers were randomized into seven age groups (years of age): 1–17; 18–29; 30–39; 40–49; 50–59; 60–69; and 70+. Regional randomization ensured proportional representation of volunteers from each region, and no more than 30 people were included from one enterprise. In accordance with manufacturer instructions, blood plasma samples were analyzed for: IgG antibodies (Abs) to the SARS-CoV-2 nucleocapsid (Nc) using a quantitative ELISA test system; and IgG Abs to the receptor binding domain (RBD) of the SARS-CoV-2 S (spike) surface glycoprotein using a qualitative ELISA test system. Statistical processing was carried out using Excel 2010 and other software. Statistical differences were designated as significant when p 0.05, unless otherwise indicated. Results. The level of seroprevalence, in terms of Abs to Nc among the Belarusian population, was 38.4% (95% CI 37.6–45.4). The highest Ab levels were found among individuals in older age groups (50-70+ years old). The lowest were found in children 1–17 years old and in young people 18–39 years old The distribution of seroprevalence across Belarusian regions was relatively homogeneous, with the exception of the Minsk Region, where a statistically significant decrease in the indicator was noted. In terms of profession, the largest share of seropositive individuals was found among transportation workers; the smallest was found in business. The moderate COVID-19 incidence has not led to a dramatic increase in the number of contacts. The base reproduction number (R0) was 1.3. In the Republic of Belarus, there was a moderate level of asymptomatic COVID-19 among seropositive individuals (45.3% [95% CI 44.0–46.7]). This form of infection was observed most often among children aged 1–17 years old (65.0% [95% CI 61.3–68.6]). In parallel with seroprevalence assessment, SARS-CoV-2 vaccination was carried out. We used two vaccines: Gam-COVID-Vac (also known as Sputnik V, developed by Gamaleya National Center for Epidemiology and Microbiology, Russia); and BBIBP-CorV (Sinopharm, PRC). Vaccination against SARS-CoV-2 was accompanied by an increase in the level of anti-RBD Abs (95% [95% CI 94.7–96.7]). Taking into account the vaccination of a subset of the population with BBIBP-CorV, the overall herd immunity, inferred from the analyzed indicators (presence of anti-Nc or anti-RBD Abs), was 47.1% (95% CI 46.3–48.0). Conclusion. COVID-19 in Belarus was characterized by a moderately pronounced course of the epidemic process. The threshold level of herd immunity to SARS-CoV-2 has not yet been reached, as a result of which the conditions for progression of the epidemic remain.

27 September 2025 in Health and Ecology Issues
Verified
Journal Article
Open access
PDF file
ADAla Dashkevich
Ala Dashkevich
NKN. D. Kolomiets
N. D. Kolomiets
ESE. O. Samoilovich
E. O. Samoilovich
IKI. A. Karaban
I. A. Karaban
Серопревалентность к вирусу SARS-CоV-2 населения Республики Беларусь

24 October 2023 in Russian Journal of Infection and Immunity
Verified
Journal Article
Open access
APAnna Yurievna Popova
Anna Yurievna Popova
VSViacheslav Smirnov
Viacheslav Smirnov
SESvetlana Alexandrovna Egorova
Svetlana Alexandrovna Egorova
ATAlexander Alexandrovich Tarasenko
Alexander Alexandrovich Tarasenko
ADAla Dashkevich
Ala Dashkevich
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Background. The course of the COVID-19 epidemic process depends on population immunity which prevents pathogen spread. Aim: to study an evolution of SARS-CoV-2 humoral immunity in the Belarusian population rela- tive to COVID-19 pandemic dynamics. Materials and methods. The work was carried out according to a methodology for assessing herd immunity developed by Rospotrebnadzor (Russia) and the Belarusian Ministry of Health involving the St. Petersburg Pasteur Institute (SPPI) by taking into account the WHO recommendations. The study was approved by the Bioethics Committee of Belarus and the SPPI Bioethics Committee. Participant selection was carried out by ques- tionnaire using a cloud (internet server) service. To monitor herd immunity, a cohort of 4661 subjects (involved at all stages of seromonitoring) was formed from the total volunteer group. Study subjects were randomized into groups based on age (117, 1829, 3039, 4049, 5059, 6069, 70+ years), geographic region, and occupation. For the detection of antibodies (Abs) against SARS-CoV-2 nucleocapsid (Nc) and S glycoprotein receptor-binding domain (RBD), rel- evant assay systems were used according to the manufacturers instructions. A four-stage study was conducted according to a unified scheme. Results. At stage 1 (pandemic month 15), herd immunity was mainly accounted for by Nc+RBD+ Ab status alone. By stage 2 (4 months later), its specific proportion decreased by 1.2-fold, whereas percentage of subjects solely bearing RBD-specific Abs increased by 1.7-fold. At stages 3 and 4 (9 and 19 months after the onset) vs. stage 2, percent- age of subjects with RBD+Nc decreased by 3.5%; the proportion of persons with Nc+RBD Abs increased by 1.5-fold. The most important contributor in herd immunity turned out to be due to population vaccination, with coverage reaching 70% by stage 4. Among vaccines, compared with whole-virion, inactivated BIBP-CorV vaccine the Sputnik V and Sputnik Light vector were used most often. Conclusion. The evolution of herd SARS-CoV-2 humoral immunity included a series of changes in circulating Ab levels (Nc, RBD). The hybrid immunity formed helped to reduce the incidence of COVID-19 to sporadic level.

1 December 2025 in Hepatology and Gastroenterology
Verified
Journal Article
Closed access
LKL. I. Kastsiukevich
L. I. Kastsiukevich
ORO. N. Romanova
O. N. Romanova
NKN. D. Kolomiets
N. D. Kolomiets
ESE. O. Samoilovich
E. O. Samoilovich
GSG. V. Semeiko
G. V. Semeiko
Background. Alterations in intestinal microbiota composition are considered one of the key triggers of inflammatory bowel disease (IBD). Studying the spectrum of enteropathogens in children with IBD helps clarify the role of an infectious factor in the disease manifestation and progression. Objective. To characterize the spectrum of enteropathogens and their associations with clinical forms of IBD in children using molecular genetic methods. Material and Methods. A total of 118 pediatric patients with IBD were examined: 36 with Crohn’s disease (CD), 54 with ulcerative colitis (UC), and 28 with indeterminate colitis (IC). Enteropathogens were identified using the TaqMan Array Card platform (Applied Biosystems, USA) covering 34 pathogens. Statistical analysis included the χ² test, Fisher’s exact test, and 95% confidence intervals. Results. Enteropathogens were detected in 56.8% (67/118) of patients with IBD. Bacteria were identified significantly more often (61.2%) than viruses and protozoa (6% each). The predominant bacterial agent was Clostridioides difficile (74.6%), found both as a single infection and within mixed infections (p<0.001). Mixed bacterial infections accounted for 24%, mainly in UC patients (p=0.01). Among viruses, rotavirus was the most frequent, while Blastocystis predominated among protozoa. Enteropathogens were significantly less common in IC patients (p<0.001). Conclusion. More than half of children with IBD harbored concomitant enteropathogens, confirming the significance of an infectious factor in disease modulation. The predominance of C. difficile and the high rate of mixed infections in ulcerative colitis emphasize the role of microbiota imbalance and support the necessity of routine molecular screening in the diagnostic algorithm for pediatric IBD. The findings highlight the need for further investigation of infectioninflammation interactions to improve prevention and therapeutic strategies.

1 June 2023 in Hepatology and Gastroenterology
Verified
Journal Article
Open access
PDF file
VVV. S. Vysotskaya
V. S. Vysotskaya
НКН. Д. Коломиец
Н. Д. Коломиец
IGI. N. Glinskaya
I. N. Glinskaya
ORO. N. Romanova
O. N. Romanova
ЕГЕ. Л. Гасич
Е. Л. Гасич
ESElena Samoilovich
Elena Samoilovich
Введение. Интеграция вакцинации против гепатита В (ГВ) в национальные программы иммунизации привела к существенному сокращению передачи вируса гепатита В (ВГВ), в том числе в ранее высокоэндемичных странах. Ключевой аспект стратегии воздействия на эпидемический процесс ГВ – введение дозы вакцины при рождении и вакцинация новорожденных. В качестве дополнительных мер воздействия важный фактор – проведение скрининга беременных женщин, использование противовирусных препаратов во время беременности, применение иммуноглобулина ГВ. Несмотря на существенное сокращение числа случаев ГВ, остается важной задачей вакцинация взрослых, прежде всего из групп высокого риска. Цель исследования. Оценить воздействие реализуемой тактики вакцинации на течение эпидемического процесса ГВ в Республике Беларусь. Материал и методы. Оценку уровней заболеваемости ГВ у населения Республики Беларусь проводили по данным форм государственной статистической отчетности. Статистическая обработка полученных результатов проводилась с помощью программы Statistica V.10.0 (Statsoft, США). Результаты. В многолетней динамике заболеваемости за анализируемый период на фоне выраженной тенденции к снижению заболеваемости острыми и бессимптомными формами ГВ с темпом снижения (Тсн.), равным -13,25% и -11,99%, соответственно, отмечается умеренная тенденция к росту для хронического гепатита В (ХГВ) с темпом прироста (Тпр.), равным +1,09%. За период 2002-2022 гг. в этиологической структуре превалирует ХГВ, составляя с 2018 г. более 70% наблюдений в общей структуре ГВ. Структура заболеваемости ГВ в разрезе регионов носит неоднородный характер. В настоящее время ведущая когорта в общей заболеваемости – население 30-49 лет. Показатель суммарной заболеваемости ГВ среди лиц данной возрастной когорты (320,57 на 100 тыс. контингента) в 2,35 раза достоверно превышает аналогичный показатель среди лиц 0-29 лет (136,50 на 100 тыс. контингента), что в определенной степени согласуется с низким уровнем охвата профилактическими прививками (по данным медицинской документации), равным для когорты 30-49 лет 39,3%. Проведение плановой вакцинопрофилактики с 2000 г. стало основой для эффективного управления эпидемическим процессом ГВ в Республике Беларусь. Выводы. В период 2002-2022 гг. установлена выраженная тенденция к снижению суммарной заболеваемости нозологическими формами ГВ с темпом, равным 7,5%, и умеренная тенденция к росту ХГВ с темпом прироста (Тпр.), равным +1,09%. Несмотря на безусловные прогресс и успехи вакцинации против ГВ, наличие более 65% непривитого взрослого населения формирует кластер для потенциального распространения вируса.